Post-traumatic stress disorder is among the most debilitating psychiatric conditions — not because it is the most common, but because it touches every dimension of a person’s life: sleep, relationships, work, and the basic sense that the world is a safe place to inhabit. Standard treatments help many people, but a significant proportion of patients with PTSD do not achieve adequate relief from first-line medications or evidence-based psychotherapies, and it is for this group that the expanding evidence base around ketamine is most relevant. At our Bellaire practice, we see many Houston-area patients whose PTSD has resisted conventional care, and we take the clinical question of how to help them seriously.
How Ketamine Addresses the Neurobiology of PTSD
IV ketamine‘s use for PTSD is off-label, meaning it has not received FDA approval for this specific indication. That distinction matters and we are transparent about it with every patient. What the research does show — across multiple controlled and open-label studies published in journals including JAMA Psychiatry and the American Journal of Psychiatry — is that ketamine produces rapid, significant reductions in PTSD symptom severity, including intrusive memories, hyperarousal, and avoidance, in a substantial proportion of patients who receive it. The mechanism appears to involve ketamine’s effects on the amygdala and hippocampus — regions critically involved in fear memory and contextual memory — and its promotion of neuroplasticity in the prefrontal cortex, which is responsible for the top-down regulation of emotional responses. In people with PTSD, these circuits are measurably dysregulated, and ketamine appears to create conditions under which they can begin to reorganize.
Ketamine-Assisted PTSD Care at Our Bellaire, TX Practice
At Dr. Prashad’s practice, the approach to ketamine for PTSD is not simply delivering infusions. The evaluation process for PTSD patients is thorough and often more complex than for patients with isolated depression. PTSD frequently co-occurs with major depression, anxiety disorders, and substance use histories, all of which need to be mapped clearly before a treatment plan is constructed. Dr. Prashad’s background as a board-certified psychiatrist, rather than a non-psychiatric provider, is particularly relevant here: she brings a comprehensive psychiatric perspective to each case, including an understanding of how trauma histories intersect with neurobiological vulnerability, how medication histories shape current receptor sensitivity, and how to sequence treatments for maximum benefit. We believe this psychiatric depth is what separates thoughtful interventional care from infusion delivery.
One of the most important aspects of ketamine for PTSD — and one that is underemphasized in discussions of the treatment — is the role of therapy in conjunction with infusions. Growing evidence, including research from institutions such as Yale and Mount Sinai, suggests that the neuroplastic window opened by ketamine may significantly enhance the effectiveness of psychotherapy when sessions are timed appropriately around infusions. This is sometimes called ketamine-assisted psychotherapy, and while formal protocols vary, the underlying concept is clinically coherent: a brain that is in a state of enhanced plasticity may be more capable of forming new, adaptive associations to replace the fear-based memories that drive PTSD symptoms. We coordinate timing around infusions for patients who are working with their own outside therapists as well.
Overcoming Barriers to PTSD Treatment in Houston
A barrier we encounter frequently with PTSD patients specifically is the concern that medical appointments, clinical settings, and the experience of discussing trauma history will themselves be triggering. This is a genuine clinical reality, and we do not minimize it. Our intake process is designed to be conducted at a pace that is tolerable for patients with significant trauma histories, and we offer flexibility around how much detail is required in the initial consultation versus what can be gathered gradually over subsequent appointments. The clinical environment at our Bellaire office is designed with this population in mind — quiet, private, and without the institutional atmosphere that many patients associate with prior difficult medical experiences.
The second barrier is cost. As with IV ketamine for depression, the off-label use of ketamine for PTSD means that most insurance plans do not cover the infusion cost. This is a real constraint, and we do not treat it as secondary. We discuss fees transparently during the consultation and encourage patients to weigh the cost against the sustained personal and professional toll of PTSD that has not responded to treatment. We also note, for patients for whom the overlap of depression and PTSD may make SPRAVATO® relevant, that SPRAVATO® is FDA-approved for treatment-resistant depression and MDD with acute suicidal ideation or behavior — not PTSD — and should be considered in that context rather than as a PTSD treatment specifically. Discuss with your provider which of these pathways makes the most sense for your individual diagnostic picture. Results vary by individual.
Frequently Asked Questions
Is ketamine FDA-approved for PTSD?
No. Ketamine’s use for PTSD is considered off-label — it has not received FDA approval for this specific indication. The evidence base comes from controlled clinical trials and observational studies demonstrating significant symptom reduction, but off-label status means this distinction should be part of every conversation with your provider before beginning treatment. At our practice, we discuss this openly during the initial consultation.
How is ketamine thought to help with PTSD symptoms?
Ketamine appears to act on the amygdala, hippocampus, and prefrontal cortex — regions that are structurally and functionally altered by chronic PTSD. Its effects on NMDA glutamate receptors promote neuroplasticity, potentially creating conditions under which the brain can begin to process and reorganize traumatic memories. It also produces rapid reductions in hyperarousal, which is one of the most debilitating symptom clusters in PTSD.
How many infusions are typically needed for PTSD?
A standard initial series involves six infusions over two to three weeks, mirroring the protocol used for treatment-resistant depression. Response patterns for PTSD can differ from depression, and the maintenance schedule — how often booster infusions may be needed — is calibrated based on your individual response. Results vary by individual, and we monitor symptom change actively throughout treatment.
Can I continue my current PTSD medications while doing ketamine?
Most patients continue their current psychiatric medications during a ketamine course. Dr. Prashad reviews your full medication list during the initial evaluation to identify any potential interactions or contraindications. Certain medications may require adjustment, and this is discussed candidly during intake.
Is therapy recommended alongside ketamine for PTSD?
Yes — based on the growing clinical literature on ketamine-assisted approaches, we actively encourage integration of therapeutic work during a ketamine course, particularly in the 24 to 72 hours after infusions when neuroplasticity is elevated. We work collaboratively with outside therapists for patients who already have a therapeutic relationship they wish to maintain.
Key Takeaways
- IV ketamine’s use for PTSD is off-label and not FDA-approved for this indication; clinical trial data supports significant symptom reduction in many patients.
- Ketamine affects amygdala, hippocampus, and prefrontal cortex — regions specifically dysregulated by chronic trauma and PTSD.
- Integrating psychotherapy during the neuroplastic window following infusions may enhance and extend treatment benefit.
- PTSD patients face specific barriers around clinical settings and cost — both are addressed directly at our Bellaire practice.
- Results vary by individual; a thorough psychiatric evaluation is required to determine whether ketamine is appropriate for your specific clinical picture.
Living with PTSD that has not responded to treatment is exhausting in a way that is difficult to communicate to anyone who has not experienced it. At our Bellaire practice, we bring both the clinical tools and the clinical sensibility to work with you in a way that respects what you have been through. If you are ready to explore whether IV ketamine belongs in your treatment path, we encourage you to schedule a consultation with Dr. Prashad. Discuss with your provider all available options, and let us be part of helping you move toward a life that is not defined by what happened to you.
References
American Journal of Psychiatry — Ketamine for PTSD: https://ajp.psychiatryonline.org/
JAMA Psychiatry — Ketamine Neuroplasticity: https://jamanetwork.com/journals/jamapsychiatry
National Center for PTSD (VA): https://www.ptsd.va.gov/
National Institute of Mental Health — PTSD: https://www.nimh.nih.gov/health/topics/post-traumatic-stress-disorder-ptsd
International Society for Traumatic Stress Studies: https://istss.org/
About Dr. Sandhya Prashad
Dr. Sandhya Prashad, MD, is a board-certified psychiatrist who has been treating patients in the Houston area since 2011, specializing in treatment-resistant depression and interventional psychiatric care. She has personally administered over 9,000 treatments for patients whose depression has not responded to traditional antidepressants, developing deep expertise in the neurobiological factors — including seasonal triggers, environmental stressors, and genetic predisposition — that shape treatment response. Dr. Prashad’s practice offers IV ketamine therapy, SPRAVATO® (esketamine), and comprehensive psychiatric evaluation, with a commitment to finding a path forward even for the most complex and long-standing cases.
Medical Disclaimer
The information provided in this article is intended for educational purposes only and does not constitute medical advice. It is not a substitute for professional psychiatric evaluation, diagnosis, or treatment. Results vary by individual, and not all patients will experience the same outcomes from ketamine therapy for PTSD. Always discuss your treatment options with a qualified medical provider before making any changes to your care plan. If you are experiencing a psychiatric emergency or thoughts of self-harm, please call 988 (Suicide and Crisis Lifeline) or go to your nearest emergency room immediately.